Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The value of continuous glucose monitoring in the management of type 1 diabetes mellitus has not been determined. METHODS: In a multicenter clinical trial, we randomly assigned 322 adults and children who were already receiving intensive therapy for type 1 diabetes to a group with continuous glucose monitoring or to a control group performing home monitoring with a blood glucose meter. All the patients were stratified into three groups according to age and had a glycated hemoglobin level of 7.0 to 10.0%. The primary outcome was the change in the glycated hemoglobin level at 26 weeks. RESULTS: The changes in glycated hemoglobin levels in the two study groups varied markedly according to age group (P=0.003), with a significant difference among patients 25 years of age or older that favored the continuous-monitoring group (mean difference in change, -0.53%; 95% confidence interval [CI], -0.71 to -0.35; P<0.001). The between-group difference was not significant among those who were 15 to 24 years of age (mean difference, 0.08; 95% CI, -0.17 to 0.33; P=0.52) or among those who were 8 to 14 years of age (mean difference, -0.13; 95% CI, -0.38 to 0.11; P=0.29). Secondary glycated hemoglobin outcomes were better in the continuous-monitoring group than in the control group among the oldest and youngest patients but not among those who were 15 to 24 years of age. The use of continuous glucose monitoring averaged 6.0 or more days per week for 83% of patients 25 years of age or older, 30% of those 15 to 24 years of age, and 50% of those 8 to 14 years of age. The rate of severe hypoglycemia was low and did not differ between the two study groups; however, the trial was not powered to detect such a difference. CONCLUSIONS: Continuous glucose monitoring can be associated with improved glycemic control in adults with type 1 diabetes. Further work is needed to identify barriers to effectiveness of continuous monitoring in children and adolescents. (ClinicalTrials.gov number, NCT00406133.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a large trial of rt-CGM in people with type 1 diabetes showing significant reductions in HbA 1c in adults (159), improved glucose control was not seen in children (ages 8 to 14 years) or adolescents and young adults (ages 15 to 24 years).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [159]
In the citing paper
“Most randomized controlled trials (RCTs) in adults with type 1 diabetes show that rt-CGM leads to lower HbA 1c (156-159) and reduced time in the hypoglycemic range (160,161).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [159]
In the citing paper
“Integration of continuous glucose monitoring (CGM) into the treatment plan soon after diagnosis improves glycemic outcomes, decreases hypoglycemic events, and improves quality of life for individuals with type 1 diabetes (18-23).”
From 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025 (2025) · cites this paper as [22]
In the citing paper
“Tamborlane and colleagues91 reported that a real-time continuous glucose monitoring system decreased the amount of time spent in hypoglycaemia (<4 mmol/L [70 mg/dL]) and lowered HbA1C when used by patients an average of 6 days a week.”
From Type 1 diabetes (2014) · cites this paper as [91]
In the citing paper
“In this study, the degree of HbA1C reduction directly correlated with higher HbA1C concentrations before beginning continuous glucose monitoring.”
From Type 1 diabetes (2014) · cites this paper as [91]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Self-citationIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Self-citationStandards of Medical Care in Diabetes—2008
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s012 · Cited by 1,377
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Self-citationEpidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90605-w · Cited by 807
Klonoff, D. C. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1231 · Cited by 724
Lachin, J. M., Genuth, S., Nathan, D. M., Zinman, B., Rutledge, B. N., & for the DCCT/EDIC Research Group (2008) · Diabetes · doi:10.2337/db07-1618 · Cited by 555
Deiss, D., Bolinder, J., Riveline, J.-P., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D., & Phillip, M. (2006) · Diabetes Care · doi:10.2337/dc06-1134 · Cited by 539
Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor
Garg, S., Zisser, H., Schwartz, S., Bailey, T., Kaplan, R., Ellis, S., & Jovanovic, L. (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1686 · Cited by 433
Research works printed but not linked: 1
- Little RJA, Rubin DB. Statistical analysis with missing data. New York: John Wiley, 1987.
Cited by
Items 801–900 of 1,001
Bruttomesso, D., Boscari, F., Lepore, G., Noaro, G., Cappon, G., Girelli, A., Bozzetto, L., Tumminia, A., Grassi, G., Sparacino, G., et al. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01020-2 · Cited by 18
Continuous glucose monitoring: long live the revolution!
Waldron-Lynch, F., & Herold, K. C. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet1044 · Cited by 15
Management of type 1 diabetes mellitus
Dennedy, M. C., & Dinneen, S. F. (2010) · Medicine · doi:10.1016/j.mpmed.2010.08.002 · Cited by 17
Iscoe, K. E., Davey, R. J., & Fournier, P. A. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0194 · Cited by 15
Use of Sensors in the Treatment and Follow-up of Patients with Diabetes Mellitus
Torres, I., Baena, M. G., Cayon, M., Ortego-Rojo, J., & Aguilar‐Diosdado, M. (2010) · Sensors · doi:10.3390/s100807404 · Cited by 17
Madrid, L., Sitoe, A., Varo, R., Nhampossa, T., Lanaspa, M., Nhama, A., Acácio, S., Galán, I. R., Casellas, A., & Bassat, Q. (2017) · Malaria Journal · doi:10.1186/s12936-017-1840-x · Cited by 16
Can composite digital monitoring biomarkers come of age? A framework for utilization
Kovalchick, C., Sirkar, R., Regele, O. B., Kourtis, L. C., Schiller, M., Wolpert, H. A., Alden, R. G., Jones, G. B., & Wright, J. M. (2017) · Journal of Clinical and Translational Science · doi:10.1017/cts.2018.4 · Cited by 16
Reach, G. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.11.002 · Cited by 17
Haslacher, H., Fallmann, H., Waldhäusl, C., Hartmann, E., Wagner, O. F., & Waldhäusl, W. K. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226132 · Cited by 15
Crossing the Technology Divide
Rubin, R. R., Borgman, S. K., & Sulik, B. (2011) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721710391107 · Cited by 15
Hermanides, J., & DeVries, J. H. (2010) · Diabetologia · doi:10.1007/s00125-009-1649-4 · Cited by 19
Charleer, S., Gillard, P., Vandoorne, E., Cammaerts, K., Mathieu, C., & Casteels, K. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13128 · Cited by 14
“However, results in the pediatric age group are less certain.(8,11,12) From 2014 onwards, intermittently scanned CGM (isCGM) (Freestyle Libre, Abbott Diabetes Care, Witney, UK) was introduced, and has been approved for use in children older than 4 years of age in January 2016.”
BackgroundFunctional data analysis for wearable sensor data: a systematic review
Acar‐Denizli, N., & Delicado, P. (2025) · AStA Advances in Statistical Analysis · doi:10.1007/s10182-025-00531-8 · Cited by 21
Continuous Glucose Monitoring and Trend Accuracy: News About a Trend Compass
Signal, M., Gottlieb, R., Compte, A. L., & Chase, J. G. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814533091 · Cited by 17
“Continuous glucose monitoring (CGM) devices are becoming increasingly used by individuals with diabetes to help control their condition [1-6].”
BackgroundFranceschi, R., Scotton, C., Leonardi, L., Cauvin, V., Maines, E., Angriman, M., Pertile, R., Valent, F., Soffiati, M., & Faraguna, U. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01882-3 · Cited by 14
Aaron, R. E., Tian, T., Yeung, A. M., Huang, J. K., Arreaza-Rubín, G., Ginsberg, B. H., Kompala, T., Lee, W.-A., Kerr, D. E., Colmegna, P. H., et al. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231201829 · Cited by 14
Kim, J. Y., Kim, J. H., & Kim, J. H. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0160 · Cited by 15
McQueen, R. B., Ellis, S. L., Maahs, D. M., Anderson, H. D., Nair, K. V., & Campbell, J. D. (2014) · Endocrine Practice · doi:10.4158/ep14027.or · Cited by 14
Closed-loop artificial pancreas: current studies and promise for the future
WEINZIMER, S. A. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283514e6b · Cited by 16
Challenges and progress in the development of a closed-loop artificial pancreas
Bequette, B. W. (2012) · Proceedings of the ... American Control Conference/Proceedings of the American Control Conference · doi:10.1109/acc.2012.6315593 · Cited by 15
Sensor-augmented pump therapy – on the way to artificial pancreas
Schönauer, M., & Thomas, A. (2010) · Avances en Diabetología · doi:10.1016/s1134-3230(10)63002-5 · Cited by 9
Sugiyama, Y., Kiuchi, C., Suzuki, M., Maruyama, Y., Wakabayashi, R. H., Ohno, Y., Takahata, S., Shibazaki, T., & Kawamata, M. (2018) · Case Reports in Anesthesiology · doi:10.1155/2018/6248467 · Cited by 15
Musolino, G., Allen, J. M., Hartnell, S., Wilinska, M. E., Tauschmann, M., Boughton, C. K., Campbell, F., Denvir, L., Trevelyan, N., Wadwa, P., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027856 · Cited by 16
Modeling continuous glucose monitoring with fractional differential equations subject to shocks
Gaetano, A. D., Sakulrang, S., Borri, A., Pitocco, D., Sungnul, S., & Moore, E. J. (2021) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2021.110776 · Cited by 14
Messer, L. H., Cook, P. F., Lowe, N. K., Hood, K. K., Driscoll, K. A., & Hernandez, T. L. (2021) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2021.11.016 · Cited by 15
The Impact of Technology on Current Diabetes Management
Garvey, K. C., & Wolfsdorf, J. I. (2015) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2015.04.005 · Cited by 16
Wainstein, J., Chimin, G., Landau, Z., Boaz, M., Jakubowicz, D. J., GODDARD, G. F. J., & Bar‐Dayan, Y. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0278 · Cited by 14
Consensus guidelines for glycemic monitoring in type 1/type 2 & GDM
Kesavadev, J., SADIKOT, S. M., WANGNOO, S. K., Kannampilly, J., Saboo, B., Aravind, S. R., Kalra, S., Makkar, B. M., Maji, D., Saikia, M., et al. (2014) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2014.04.030 · Cited by 18
El Páncreas Artificial: Control Automático de Infusión de Insulina en Diabetes Mellitus Tipo 1
Bondía, J., Vehí, J., Palerm, C. C., & Herrero, P. (2010) · Revista Iberoamericana de Automática e Informática Industrial RIAI · doi:10.1016/s1697-7912(10)70021-2 · Cited by 27
Continuous glucose monitoring system ( CGMS ) in kidney‐transplanted children
Pásti, K., Szabo, A. J., Prókai, Á., Meszaros, K., Peko, N., Sólyom, R., Sallay, P., Reusz, G., & Rusai, K. (2013) · Pediatric Transplantation · doi:10.1111/petr.12106 · Cited by 14
Iwaz, J. A., & Maisel, A. S. (2016) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2016.1158105 · Cited by 14
Tsujino, D., Nishimura, R., Onda, Y., Seo, C., Ando, K., Morimoto, A., & Utsunomiya, K. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0167-z · Cited by 18
Role of Continuous Glucose Monitoring in Insulin-Requiring Patients with Diabetes
Welsh, J. B. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0100 · Cited by 17
Flokas, M. E., Zeymo, A., Méte, M., Anhalt, H., Rother, K. I., & Gourgari, E. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.107513 · Cited by 19
Improving Linear Range Limitation of Non-Enzymatic Glucose Sensor by OH− Concentration
Yang, L. W., Liu, E. E., Xu, F., Chen, J. Y., Wang, R. T., & Xu, G. (2020) · Crystals · doi:10.3390/cryst10030186 · Cited by 14
β-cell replenishment: Possible curative approaches for diabetes mellitus
RATHWA, N. N., Patel, R., Palit, S. P., PARMAR, N. R., Rana, S., Ansari, M. I., Ramachandran, A. V., & Begum, R. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.08.006 · Cited by 18
A novel tool to predict youth who will show recommended usage of diabetes technologies
Neylon, O. M., Skinner, T. C., O’Connell, M. A., & Cameron, F. J. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12253 · Cited by 14
Taki, K., Nishimura, R., Morimoto, A., Tsujino, D., Miyashita, Y., & Tajima, N. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0167 · Cited by 14
Sperling, M. A., Tamborlane, W. V., Battelino, T., WEINZIMER, S. A., & Phillip, M. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00028-7 · Cited by 16
Insulin Pump Therapy With Automated Insulin Suspension: Toward Freedom From Nocturnal Hypoglycemia
Choudhary, P. (2013) · JAMA · doi:10.1001/jama.2013.278576 · Cited by 15
Outcome Measures for Outpatient Hypoglycemia Prevention Studies
Beck, R. W., Kollman, C., Xing, D., Buckingham, B. A., & Chase, H. P. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500423 · Cited by 14
Battelino, T., Edelman, S. V., Nishimura, R., & Bergenstal, R. M. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0180 · Cited by 13
Kim, J. Y., Kim, S., & Kim, J. H. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0804 · Cited by 13
Rueter, P., Farrell, K., Phelan, H., Colman, P. G., Craig, M. E., Gunton, J. E., Holmes-Walker, D. J., & the ADDN study group, A. S. G. (2021) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.295 · Cited by 13
Making sense of glucose sensors in end-stage kidney disease: A review
Williams, M. E., Steenkamp, D., & Wolpert, H. A. (2022) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2022.1025328 · Cited by 14
Institutional role conflict in the digital age: The case of diabetes management at school
Puckett, C., Wong, J. C., Talbot, S., Min, H. J., & Chokr, N. (2022) · SSM - Qualitative Research in Health · doi:10.1016/j.ssmqr.2022.100215 · Cited by 15
“Studies show numerous benefits: pumps and CGM can improve glycemic control, reduce hypoglycemia, and reduce diabetes burden when used regularly (Pańkowska et al., 2009; Pickup & Sutton, 2008; Tamborlane et al., 2008; Wong et al., 2014).”
BackgroundChan, N. B., Li, W., Aung, T., Bazuaye, E., & Montero, R. (2023) · JMIR AI · doi:10.2196/45450 · Cited by 19
Zhao, Z., Ke, X., Huang, J., Zhang, Z., Wu, Y., Huang, G., Tan, J., Liu, X., Mei, Y., & Chu, J. (2024) · Advanced Science · doi:10.1002/advs.202310189 · Cited by 13
Züger, T., Diem, P., Mougiakakou, S. G., & Stettler, C. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0271 · Cited by 15
Continuous glucose monitoring‐enabled insulin‐pump therapy in diabetic pregnancy
Secher, A. L., Schmidt, S., Nørgaard, K., & Mathiesen, E. R. (2010) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016349.2010.498499 · Cited by 13
The latest pharmacotherapy options for type 1 diabetes
Ludvigsson, J. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.855197 · Cited by 13
Economic impact of hypoglycemia among insulin-treated patients with diabetes
Sussman, M. S., Sierra, J. A., Garg, S. K., Bode, B. W., Friedman, M., Gill, M., KAUFMAN, F. R., Vigersky, R. A., & Menzin, J. (2016) · Journal of Medical Economics · doi:10.1080/13696998.2016.1201090 · Cited by 17
Toschi, E., Fisher, L., Wolpert, H. A., Love, M., Dunn, T. C., & Hayter, G. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818791534 · Cited by 15
Smith, M. B., Albanese-O’Neill, A., Yao, Y., Wilkie, D. J., Haller, M. J., & Keenan, G. M. (2021) · JMIR Diabetes · doi:10.2196/15410 · Cited by 15
Stimson, R. H., Dover, A. R., Ritchie, S. A., Wright, R. J., McKnight, J. A., Zammitt, N. N., & Gibb, F. W. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001292 · Cited by 14
Levy, C. J., Foster, N. C., DuBose, S. N., Agarwal, S., Lyons, S. K., Peters, A. L., Uwaifo, G. I., DiMeglio, L. A., Sherr, J. L., & Polsky, S. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820972123 · Cited by 14
Rubelj, K. (2021) · Acta Clinica Croatica · doi:10.20471/acc.2021.60.04.07 · Cited by 13
Noor, N., Norman, G. J., Sonabend, R., Chao, L. C., Kamboj, M. K., Golden, L., Bekx, M. T., Hseih, S., Levy, C. J., Sanchez, J. E., et al. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231178017 · Cited by 15
Langeland, L. B. L., Salvesen, Ø. O., Selle, H., Carlsen, S. M., & Fougner, K. J. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02947.x · Cited by 14
Drab, S. R. (2009) · Journal of the American Pharmacists Association · doi:10.1331/japha.2009.08181 · Cited by 14
An inexpensive device for monitoring patients' weights via automated hovering
Shaffer, J. A., Diaz, K. M., Alcántara, C., Edmondson, D. E., Krupka, D. J., Chaplin, W. F., & Davidson, K. W. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.12.123 · Cited by 16
“Remote hovering practices have gained considerable traction during the past several years [3–7], but their use outside of research settings has been limited.”
BackgroundAust, H., Dinges, G., Nardi-Hiebl, S., Koch, T., Lattermann, R., Schricker, T., & Eberhart, L. H. J. (2014) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2014.02.022 · Cited by 15
Recent Advances in Translational Work on Implantable Sensors
Black, R. D. (2011) · IEEE Sensors Journal · doi:10.1109/jsen.2011.2166995 · Cited by 17
Emerging Technologies for the Management of Type 1 Diabetes in Pregnancy
Yamamoto, J. M., & Murphy, H. R. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0973-9 · Cited by 16
Wysocki, M., Szopa, M., Stefura, T., Dudek, A., Torbicz, G., Gajewska, N., Pędziwiatr, M., Małczak, P., Pisarska, M., Budzynski, A. Z., et al. (2019) · Obesity Surgery · doi:10.1007/s11695-018-03684-5 · Cited by 15
Puhr, S., Calhoun, P. M., Welsh, J. B., & Walker, T. C. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0134 · Cited by 17
Fathi, A. E., Palisaitis, E., Oettingen, J. E. V., Krishnamoorthy, P., Kearney, R. E., Legault, L., & Haidar, A. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13052 · Cited by 16
Schöttler, H., Auzanneau, M., Best, F., Braune, K., Freff, M., Heidtmann, B., Jung, R., Karges, B., Klee, D., Müller, A., et al. (2020) · Diabetologie und Stoffwechsel · doi:10.1055/a-1259-1190 · Cited by 15
“[11] Tamborlane WV, Beck RW, Bode BW et al.”
Backgroundde Leiva, A., de Leiva-Pérez, A., & Brugués, E. (2011) · Avances en Diabetología · doi:10.1016/s1134-3230(11)70004-7 · Cited by 13
From pumps to prevention: recent advances in the treatment of type 1 diabetes
Sherr, J. L., Cengiz, E., & Tamborlane, W. V. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.06.011 · Cited by 16
Clinical Requirements for Closed-Loop Control Systems
Clarke, W. L., & Renard, É. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600233 · Cited by 16
Schechter, A., Eyal, O., Zuckerman-Levin, N., Amihai-Ben-Yaacov, V., Weintrob, N., & Shehadeh, N. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0002 · Cited by 12
“14 The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group 15 demonstrated that only 21% of the pediatric cohorts with type 1 diabetes mellitus were able to continue the frequent use of these devices.”
Zandona, A., Vettoretti, M., Longato, E., Li, Y., Madondo, K., Pagan, J., Siscovick, D. S., & Di Camillo, B. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.2525.abstracts · Cited by 15
Yan, Q., Li, D., Jia, S., Yang, J., & Ma, J. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108688 · Cited by 13
Nanomaterials for diabetes: diagnosis, detection and delivery
Verma, J., & Dahiya, S. (2024) · Nanotechnology · doi:10.1088/1361-6528/ad5db5 · Cited by 12
“The usual course of treatment consists of basal injections of long-acting insulin (which has a longer plasma half-life than ordinary insulin) and bolus injections of fast-acting insulin (which has a shorter plasma half-life) at mealtimes [12, 13].”
Blood Pressure Time in Target Range and its Impact on Clinical Outcomes
Al-Dalakta, A., Tabaja, C., Motairek, I. K., Hajjar, A. H. E., Agarwal, N., John, J. S., & Laffin, L. J. (2024) · Current Cardiology Reports · doi:10.1007/s11886-024-02111-9 · Cited by 16
Asl, Z. R., Rezaee, K., Ansari, M., Zare, F., & Roknabadi, M. H. A. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135988 · Cited by 15
Evidence for continuous glucose monitoring: sufficient for reimbursement?
Heinemann, L., & DeVries, J. H. (2014) · Diabetic Medicine · doi:10.1111/dme.12341 · Cited by 15
Choudhary, P., Lonnen, K., Emery, C., Freeman, J. V., McLeod, K. M., & Heller, S. R. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0059 · Cited by 13
Continuous glucose monitoring: coming of age?
DeVries, J. H. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1127 · Cited by 12
Leelarathna, L., Dellweg, S., Mader, J. K., Barnard, K. D., Benesch, C., Ellmerer, M., Heinemann, L., Kojzar, H., Thabit, H., Wilinska, M. E., et al. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-006075 · Cited by 14
von Schwartzenberg, R. J., & Turnbaugh, P. J. (2015) · Cell · doi:10.1016/j.cell.2015.11.012 · Cited by 12
Automated Insulin Delivery—The Light at the End of the Tunnel
Turksoy, K., Frantz, N., Quinn, L., Dumin, M., Kilkus, J. M., Hibner, B. A., Çınar, A., & Littlejohn, E. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.02.055 · Cited by 14
Real-time Monitoring of Biomarkers: Current Status and Future Perspectives
Paek, S. (2020) · BioChip Journal · doi:10.1007/s13206-020-4101-y · Cited by 12
Monnier, L., Colette, C., & Owens, D. R. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.06.004 · Cited by 13
Fuchs, J., Allen, J. M., Boughton, C. K., Wilinska, M. E., Thankamony, A., de Beaufort, C. E., Campbell, F., Yong, J., Froehlich‐Reiterer, E., Mader, J. K., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-042790 · Cited by 12
Irace, C., Cutruzzolà, A., Tweden, K. S., & KAUFMAN, F. R. (2021) · Expert Review of Medical Devices · doi:10.1080/17434440.2021.1982380 · Cited by 14
Rose, S., Styles, S. E., Wiltshire, E. J., Stanley, J., Galland, B. C., de Bock, M. I., Tomlinson, P. A., Rayns, J. A., MacKenzie, K. E., & Wheeler, B. J. (2021) · Diabetic Medicine · doi:10.1111/dme.14756 · Cited by 13
Huo, L., Deng, W., Lan, L., Li, W., Shaw, J. E., Magliano, D. J., & Ji, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.891718 · Cited by 13
“Age at diagnosis (years) 17 (10, 28) 12 (8, 21) 18 (10, 29) 0.”
Methodvan Beers, C. A. J., Kleijer, S. J., Serné, E. H., Geelhoed-Duijvestijn, P. H. L. M., Snoek, F. J., Kramer, M. H. H., & Diamant, M. (2015) · BMC Endocrine Disorders · doi:10.1186/s12902-015-0040-3 · Cited by 14
Dave, K. R., Pileggi, A., & Raval, A. P. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.03.079 · Cited by 13
Medical Treatment of Diabetes Mellitus
Skugor, M. (2017) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.84.s1.07 · Cited by 14
McCabe, M., Hála, P., Rojas-Peña, Á., Lautner‐Csorba, O., Major, T. C., Ren, H., Bartlett, R. H., Brisbois, E. J., & Meyerhoff, M. E. (2019) · Talanta · doi:10.1016/j.talanta.2019.06.077 · Cited by 12
Improved blood glucose estimation through multi-sensor fusion
Xiong, F., Hipszer, B. R., Joseph, J. I., & Kam, M. (2011) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2011.6090122 · Cited by 12
Accuracy of continuous glucose monitoring system during exercise in type 2 diabetes
Figueira, F. R., Umpierre, D., Ribeiro, J. P., Tetelbom, P. S., Henn, N. T., Esteves, J., & Schaan, B. D. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.09.033 · Cited by 12
“Ideally, measurements should reflect all usual activities, including physical exercise, a widely recommended intervention in the treatment of these patients [7–14].”
BackgroundStrategies to Increase Adherence through Diabetes Technology
Gabbay, R. A., & Durdock, K. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400322 · Cited by 13
Methods of Evaluating the Utility of Continuous Glucose Monitor Alerts
Kamath, A., Mahalingam, A., & Brauker, J. H. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400108 · Cited by 13
Non-invasive Analytics Based Smart System for Diabetes Monitoring
Saravanan, M., & Shubha, R. (2018) · Lecture notes of the Institute for Computer Sciences, Social Informatics and Telecommunications Engineering · doi:10.1007/978-3-319-76213-5_13 · Cited by 12
Psychological Factors and Diabetes Mellitus
Pouwer, F., & Speight, J. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch56 · Cited by 12
Saboo, B., Garg, S. K., Bergenstal, R. M., Battelino, T., Ceriello, A., Choudhary, P., de Bock, M. I., Elbarbary, N. S., Forlenza, G. P., Gómez, A. M., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.0028 · Cited by 12
Metadata
- Authors
- The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
- Affiliations
- Yale University (US)
- Corresponding author
- The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-10-02
- Volume
- 359
- Issue
- 14
- Pages
- 1464-1476
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1531505795
- Semantic Scholar
- b1462f3524589cf66909ea165b57d41352a0293b
- Cited by
- 1,559
- References
- 30
- Citations by year
- 2026: 29 · 2025: 60 · 2024: 64 · 2023: 54 · 2022: 61 · 2021: 103 · 2020: 104 · 2019: 90 · 2018: 109 · 2017: 101 · 2016: 95 · 2015: 85 · 2014: 79 · 2013: 86 · 2012: 104
- FWCI
- 79.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- continuous glucose monitoring, type 1 diabetes, intensive insulin therapy, HbA1c, glycemic control, age differences, children and adolescents, severe hypoglycemia
- MeSH terms
- Adolescent, Adult, Analysis of Variance, Blood Glucose, Child, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Injections, Subcutaneous, Insulin, Insulin Infusion Systems, Male, Blood Glucose Self-Monitoring, Monitoring, Ambulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.